CLINICAL_TRIALS
research
· 2026-04-16
Clinical Trial Update: Ischemic And Bleeding Risk Assessment After TAVR
Summary
This clinical trial update reports a study assessing ischemic and bleeding risk after transcatheter aortic valve replacement (TAVR) in patients with aortic valv…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Niguarda Hospital | Conditions: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement | Status: RECRUITING